CCR5 and HIV infectious disease: Unlike individuals with two copies of the mutation CCR5Δ32 who are protected from HIV infection by non-functionality of CCR5 [43,44,45], heterozygous individuals for this mutation can be infected by HIV R5 strains but exhibit an altered activity of the chemokine receptor, resulting in delayed progression to AIDS [46,47,48].